BHIC (BioScience Health Innovations) EPS without NRI: $0.00 (TTM As of Mar. 2026)


BHIC BioScience Health Innovations Inc BHIC
47 GF Score
Price $4.34
GF Value $164.84
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is BioScience Health Innovations EPS without NRI?

BioScience Health Innovations BHIC +6.22% 47 EPS without NRI is $0.00 as of Mar. 2026. GuruFocus rates BHIC with a GF Score™ of 47/100 and a GF Value™ of $164.84 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 513 Healthcare Providers & Services companies, BioScience Health Innovations ranks worse than 194931.58% on this metric.

BioScience Health Innovations's earnings per share without non-recurring items for the three months ended in Mar. 2026 was $-0.02. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was $0.00.

During the past 12 months, BioScience Health Innovations's average earnings per share (NRI) Growth Rate was -100.00% per year. During the past 10 years, the average earnings per share (NRI) Growth Rate was 0.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for BioScience Health Innovations's EPS without NRI or its related term are showing as below:

During the past 7 years, BioScience Health Innovations's highest 3-Year average Earnings Per Share (NRI) Growth Rate was -71.00% per year. The lowest was -71.00% per year. And the median was -71.00% per year.

BHIC's 3-Year EPS without NRI Growth Rate is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 11.6
* Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.

BioScience Health Innovations's EPS (Diluted) for the three months ended in Mar. 2026 was $-0.02. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was $0.00.

BioScience Health Innovations's EPS (Basic) for the three months ended in Mar. 2026 was $-0.02. Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 was $0.00.


BioScience Health Innovations  (OTCPK:BHIC) EPS without NRI Explanation

EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


BioScience Health Innovations EPS without NRI Related Terms


BioScience Health Innovations EPS without NRI Historical Data

* Premium members only.

The historical data trend for BioScience Health Innovations's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BioScience Health Innovations EPS without NRI Chart

BioScience Health Innovations Annual Data
Trend Aug19 Aug20 Aug21 Aug22 Dec23 Dec24 Dec25
EPS without NRI
Get a 7-Day Free Trial -0.02 -0.09 -0.04 0.01 0.06

BioScience Health Innovations Quarterly Data
May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EPS without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.01 0.04 0.00 -0.02 -0.02

BHIC vs SHFH, PETS, SCNX: EPS without NRI Comparison

For the Pharmaceutical Retailers subindustry, BioScience Health Innovations's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BioScience Health Innovations PE Ratio without NRI vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, BioScience Health Innovations's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where BioScience Health Innovations's PE Ratio without NRI falls into.


BHIC
47GF Score
BioScience Health Innovations Inc BHIC
EPS without NRI is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BioScience Health Innovations EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.

EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS without NRI →
What does a EPS without NRI of $0.00 mean?
BioScience Health Innovations (BHIC) has a EPS without NRI of $0.00 as of Mar. 2026. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on BioScience Health Innovations and its competitors. According to the industry distribution chart, BioScience Health Innovations ranks #999999 out of 513 companies in the Healthcare Providers & Services industry.
Is BioScience Health Innovations' EPS without NRI too high?
BioScience Health Innovations' current EPS without NRI is $0.00. Based on the distribution chart, BioScience Health Innovations ranks #999999 out of 513 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, BioScience Health Innovations has a GF Score™ of 47/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does BioScience Health Innovations' EPS without NRI compare to SHFH and PETS?
According to the Healthcare Providers & Services industry distribution chart, BioScience Health Innovations ranks #999999 out of 513 companies for EPS without NRI. This places BioScience Health Innovations in the lower half of its industry. The industry median EPS without NRI is 11.60. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS without NRI for a Healthcare Providers & Services company?
The median EPS without NRI among Healthcare Providers & Services companies is 11.60, based on 513 companies in the industry. Companies in the top quartile (top 25%) have a EPS without NRI significantly above this median, while those in the bottom quartile fall well below. However, EPS without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS without NRI mean?
A high EPS without NRI can signal that a stock is expensive relative to its fundamentals. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on BioScience Health Innovations and its competitors. For the Healthcare Providers & Services industry, the median EPS without NRI is 11.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. BioScience Health Innovations's current EPS without NRI is $0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BioScience Health Innovations stock overvalued right now?
Based on GuruFocus' analysis, BioScience Health Innovations (BHIC) is currently considered Possible Value Trap. The stock's GF Value™ is $164.84, compared to a current price of $4.34 — trading 97.4% below its estimated fair value. The current EPS without NRI is $0.00. BioScience Health Innovations' overall GF Score™ is 47/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS without NRI calculated?
EPS without NRI is calculated from a company's financial statements. For BioScience Health Innovations (BHIC), the current EPS without NRI is $0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is BioScience Health Innovations (BHIC) Overvalued in 2026?

Based on GuruFocus' analysis, BioScience Health Innovations stock appears to be undervalued. The current stock price of $4.34 is trading 97.4% below its estimated GF Value™ of $164.84. GuruFocus considers BioScience Health Innovations to be Possible Value Trap.

Key valuation signals for BHIC:

  • EPS without NRI: $0.00
  • GF Value™: $164.84 vs. price of $4.34 (97.4% below fair value)
  • GF Score™: 47/100 with 5 warning signs

No single metric tells the full story. See the BHIC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


BioScience Health Innovations Business Description

Address 14857 South Concord Park Drive, Bluffdale, UT, USA, 84065
BioScience Health Innovations Inc is engaged in full-scale operations as a distributor and generates revenue. The company's main business is to sell clinically tested, affordably priced products to naturally battle the onslaught of bacteria and viruses through online sales and various other distribution channels. The company develops, manufactures, and distributes science-backed nutritional supplements and delivery systems targeting cellular health, mitochondrial optimization, hormonal balance, and longevity.
47GF Score

Get the complete analysis for BHIC

EPS without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.34
Price
$164.84
GF Value